It’s not just AI. China’s medicines are surprising the world, too
Keytruda, a cancer medicine, ranks among the most lucrative drugs ever sold. Since its launch in 2014 it has raked in more th...
How Trump’s One-for-One Tariff Plan Threatens the Global Economy
The world economy was already grappling with a perplexing assortment of variables, from geopolitical conflicts and a slowdown...
What Happens to Global Trade If ‘the W.T.O. Is Toast’?
When President Trump announced that he would impose new tariffs on imports from countries around the world, he launched a f...
Chinese cars are taking over the global south
“Styling, build quality and polish” were “frankly lacklustre”. The review in Car and Driver, a respected motoring publication...
Could a German startup disrupt Europe’s arms industry?
In the 1980s Robert Solow, an economist, remarked that you could see the computer age everywhere except the productivity stat...
Defence tech is blowing up Silicon Valley’s beliefs
IN THE BACK of an unmarked office building close to LAX, the main airport of Los Angeles, stands a rack of unarmed hypersonic...
How to get people to resign
The gut reaction that a manager has when an employee announces their resignation is telling. Sometimes it is genuine dismay: ...
Honda and Nissan Scrap $50 Billion Merger Plan
A $50 billion merger between Honda Motor and Nissan Motor, which would have established one of the world’s largest auto gro...
Elon Musk’s $97bn offer is a nuisance for Sam Altman’s OpenAI
For most startups, a buyout offer nearing $100bn is something to be celebrated. But OpenAI is not like other startups—and Elo...
Elon Musk’s $97bn offer is a headache for Sam Altman’s OpenAI
For most startups, a buyout offer nearing $100bn is something to be celebrated. But OpenAI is not like other startups—and Elo...